Holger Wesche, Chief Scientific Officer at Harpoon Therapeutics, Inc. (HARP), sold 12,700 shares at $14.13 ($179K) on 2020-05-07, disclosed to the SEC on 2020-05-11.
Open-market sale of $179k HARP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.13 | 5,350 | $76K | 42.2% |
| 2 | $14.13 | 5,350 | $76K | 42.2% |
| 3 | $14.00 | 1,000 | $14K | 7.8% |
| 4 | $14.07 | 1,000 | $14K | 7.8% |
| Total | $14.12 avg | 12,700 | $179K | 100% |
| Filing → |
| HARP | SELL | 2021-01-06 | $314K | — | Filing → |
| HARP | SELL | 2020-10-05 | $163K | — | Filing → |
| HARP | SELL | 2020-07-02 | $162K | — | Filing → |